tirzepatide facebook Medscape - The SURPASS-PEDS trial shows delivers durable glycemic control and weight benefit in youth with type 2 diabetes, the first therapy to show this effect. http://ms.spr.ly/6180sWS1i Mission - 📣 Tirzepatide Program

The post describes GIP receptor activation as enhancing insulin secretion and reducing appetite through neural pathways distinct from GLP-1, which is why tirzepatide is called a dual agonist rather than a single-target one

They also help to reduce inflammation in the body and support overall health and wellbeing

The higher cost requirement sets a higher commercial threshold for biologic investments to be value-creating

FDA has documented over 400 adverseevent reports with compounded semaglutide and 300 with compounded tirzepatide, though the Alliance for Pharmacy Compounding disputes the reliability of those data